Pre Clinical Trial Testing Articles & Analysis
3 news found
Funding from the Series B will allow Oligomerix to accelerate its transition into Phase 1 human clinical development planned for early 3Q 2022. Oligomerix closes Series B extension to accelerate transition into Phase 1 human clinical development. ...
Abologix develops a new therapeutic option to treat lymphoma patients who have become resistant to conventional treatments. The Geneva-based biotech startup is a spin-out from the laboratories at the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG). Abologix will use the CHF 150,000 to advance the preclinical development of its product, refine its commercial and competitive ...
ByAbologix
The poster details the results of Selux's latest pre-clinical trial testing on its trial prototype instruments. Rapid, Comprehensive-Menu Antimicrobial Susceptibility Testing Directly from Positive Blood Cultures: Saturday, Jun. 22, 2019; Presentation Time 1: 11 am-12 pm, Presentation Time 2: ...